T161 Pill - orange oval, 18mm
Pill with imprint T161 is Orange, Oval and has been identified as Mycophenolic Acid Delayed-Release 360 mg. It is supplied by TWi Pharmaceuticals, Inc.
Mycophenolic acid is used in the treatment of Rejection Prophylaxis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolic acid 360 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for T161
Mycophenolic Acid Delayed-Release
- Imprint
- T161
- Strength
- 360 mg
- Color
- Orange
- Size
- 18.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- TWi Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 24979-0160
- Inactive Ingredients
-
lactose anhydrous,
crospovidone,
FD&C Yellow No. 6,
hypromellose 2910 (3 mPa.s),
hypromellose 2910 (6 mPa.s),
hypromellose phthalate,
magnesium stearate,
corn starch,
polyethylene glycol,
povidone k30,
talc,
titanium dioxide,
triethyl citrate
Note: Inactive ingredients may vary.
Related images for "T161"
More about mycophenolic acid
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (8)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
